In Brief: Longtime Industry Expert Kim Trautman Joins RAPS Board; FDA Announces Safety Communications Meeting
The Regulatory Affairs Professionals Society has added former US FDA official Kim Trautman to its board of directors. Also: The agency will hold a public meeting on April 1 to focus on its safety communications for medical devices.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.